Thoracoscopic appendage exclusion with an atriclip device as a solo treatment for focal atrial tachycardia.
نویسندگان
چکیده
A 15-year-old boy with incessant drug-refractory atrial tachycardia was referred to our department for an ablation procedure. The tachycardia was diagnosed at 13 years of age during routine medical screening for soccer competition. Despite the administration of metoprolol, verapamil, and flecainide, the arrhythmia persisted and ventricular response was not controlled. Physical examination was normal except for a heart rate of 130 bpm; no signs of congestive heart failure were found. Blood examinations revealed normal thyroid function. Twelve-lead ECG showed a narrow QRS tachycardia with positive P waves in II-III-aVF-V1-V2 leads, negative P waves in I-aVL leads, and a short PR interval (Figure 1), suggesting a left atrial origin.1,2 Transthoracic echocardiography showed normal left ventricular size with normal systolic function and normal atrial volumes. During electrophysiological study, the earliest atrial activation during tachycardia was located on the distal bipole of the coronary sinus catheter, confirming a lateral left atrial origin.1–3 Left atrial access was obtained by transseptal approach with a Brockenbrough needle. Electroanatomic mapping, performed with the CARTO 3 mapping system (Biosense-Webster Diamond Bar, CA), showed a normal left atrial morphology and an eccentric atrial activation from the distal portion of the left atrial appendage (Figure 2).1–3 Radiofrequency was delivered at the site where the earliest local electrogram preceded atrial activation on the distal coronary sinus by 48 milliseconds. However, tachycardia relapsed despite 2 percutaneous ablation attempts (Figure 3). To eliminate the arrhythmia, epicardial exclusion of the appendage with a minimally invasive occlusion device (Atriclip, AtriCure Inc) was decided. The clip is composed of 2 parallel, straight, rigid titanium tubes covered with a knitbraided polyester sheath. It is designed to be implanted from outside the heart through a thoracoscopic approach.4 In January 2010, the patient underwent the thoracoscopic procedure under general anesthesia with dual-lumen intubation. Three ports were positioned: 1 (5 mm) in the third intercostal space, 1 (10 mm) in the sixth space at the median axillary level, and 1 (10 mm) in the fifth space on the posterior axillary line. Pericardiotomy was performed parallel and posterior to the phrenic pedicle to expose the left atrial
منابع مشابه
Late Dehiscence of Left Atrial Appendage Closure Device.
A 68-year-old male with history of hypertension, diabetes mellitus, and persistent atrial fibrillation (AF) refractory to amiodarone (CHA 2 DS 2 -VASc score of 3) underwent a successful total thoracoscopic surgical ablation of AF (mini-maze) procedure in August 2011. A transesophageal echocardiogram (TEE) performed before the procedure revealed no evidence of thrombus in the left atrial appenda...
متن کاملSuccessful fluoroless ablation of an incessant atypical atrial flutter attributed to AtriClip usage during mini-MAZE surgery for persistent atrial fibrillation
Introduction The AtriClip left atrial appendage (LAA) exclusion device (AtriCure Inc, Westchester, OH) is a surgical LAA closure device frequently used in conjunction with thoracoscopyguided mini-MAZE surgery to treat atrial fibrillation (AF). It is composed of 2 parallel titanium bars, which provide constant tension when deployed. The AtriClip is coated with polyester fabric, which promotes ti...
متن کاملA Semi-Automated Algorithm for Segmentation of the Left Atrial Appendage Landing Zone: Application in Left Atrial Appendage Occlusion Procedures
Background: Mechanical occlusion of the Left atrial appendage (LAA) using a purpose-built device has emerged as an effective prophylactic treatment in patients with atrial fibrillation at risk of stroke and a contraindication for anticoagulation. A crucial step in procedural planning is the choice of the device size. This is currently based on the manual analysis of the “Device Landing Zone” fr...
متن کاملAtrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation [PROTECT-AF] and Prospective Randomized Evaluation of the WATCHMAN LAA Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy
To the Editor: We read with great interest the report by Whitlock et al, who have highlighted the fact that the left atrial appendage (LAA) occlusion is an effective concept for stroke-prevention in patients with atrial fibrillation. The data presented in this report demonstrate improving safety and efficacy data on LAA occlusion with a noninferiority and even superiority to warfarin treatment ...
متن کاملIs there an alternative treatment for patients intolerant to antiplatelet therapy if percutaneous left atrial appendage closure is considered?
INTRODUCTION Left atrial appendage (LAA) closure has become of major interest for patients with atrial fibrillation intolerant to oral anticoagulation therapy (OAC). Patients with a contraindication to both OAC and antiplatelet therapy are not eligible for percutaneous LAA closure. We aimed to find an alternative treatment for these specific patients. METHODS From March 2014 until December 20...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Circulation
دوره 123 14 شماره
صفحات -
تاریخ انتشار 2011